565 related articles for article (PubMed ID: 16333030)
1. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC
J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030
[TBL] [Abstract][Full Text] [Related]
2. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer.
Osipo C; Gajdos C; Liu H; Chen B; Jordan VC
J Natl Cancer Inst; 2003 Nov; 95(21):1597-608. PubMed ID: 14600092
[TBL] [Abstract][Full Text] [Related]
4. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL; Elferink C; Novak RF
J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
[TBL] [Abstract][Full Text] [Related]
5. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin.
Lim DY; Park JH
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol.
Song RX; Mor G; Naftolin F; McPherson RA; Song J; Zhang Z; Yue W; Wang J; Santen RJ
J Natl Cancer Inst; 2001 Nov; 93(22):1714-23. PubMed ID: 11717332
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
[TBL] [Abstract][Full Text] [Related]
8. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
Seeger H; Wallwiener D; Kraemer E; Mueck AO
Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
[TBL] [Abstract][Full Text] [Related]
9. Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53.
Ho TF; Ma CJ; Lu CH; Tsai YT; Wei YH; Chang JS; Lai JK; Cheuh PJ; Yeh CT; Tang PC; Tsai Chang J; Ko JL; Liu FS; Yen HE; Chang CC
Toxicol Appl Pharmacol; 2007 Dec; 225(3):318-28. PubMed ID: 17881028
[TBL] [Abstract][Full Text] [Related]
10. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
[TBL] [Abstract][Full Text] [Related]
11. Testosterone promotes apoptotic damage in human renal tubular cells.
Verzola D; Gandolfo MT; Salvatore F; Villaggio B; Gianiorio F; Traverso P; Deferrari G; Garibotto G
Kidney Int; 2004 Apr; 65(4):1252-61. PubMed ID: 15086464
[TBL] [Abstract][Full Text] [Related]
12. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells.
Mooney LM; Al-Sakkaf KA; Brown BL; Dobson PR
Br J Cancer; 2002 Oct; 87(8):909-17. PubMed ID: 12373608
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.
Obrero M; Yu DV; Shapiro DJ
J Biol Chem; 2002 Nov; 277(47):45695-703. PubMed ID: 12244117
[TBL] [Abstract][Full Text] [Related]
15. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.
Ariazi EA; Cunliffe HE; Lewis-Wambi JS; Slifker MJ; Willis AL; Ramos P; Tapia C; Kim HR; Yerrum S; Sharma CG; Nicolas E; Balagurunathan Y; Ross EA; Jordan VC
Proc Natl Acad Sci U S A; 2011 Nov; 108(47):18879-86. PubMed ID: 22011582
[TBL] [Abstract][Full Text] [Related]
16. Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells.
Takahashi K; Loo G
Biochem Pharmacol; 2004 Jan; 67(2):315-24. PubMed ID: 14698044
[TBL] [Abstract][Full Text] [Related]
17. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway.
Patil JB; Kim J; Jayaprakasha GK
Eur J Pharmacol; 2010 Oct; 645(1-3):70-8. PubMed ID: 20691179
[TBL] [Abstract][Full Text] [Related]
18. Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.
Sanchez CG; Ma CX; Crowder RJ; Guintoli T; Phommaly C; Gao F; Lin L; Ellis MJ
Breast Cancer Res; 2011 Mar; 13(2):R21. PubMed ID: 21362200
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin.
Soto-Cerrato V; Llagostera E; Montaner B; Scheffer GL; Perez-Tomas R
Biochem Pharmacol; 2004 Oct; 68(7):1345-52. PubMed ID: 15345324
[TBL] [Abstract][Full Text] [Related]
20. p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines.
Fernandez-Cuesta L; Anaganti S; Hainaut P; Olivier M
Int J Cancer; 2011 Apr; 128(8):1813-21. PubMed ID: 20549698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
